Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-070393
Filing Date
2025-04-01
Accepted
2025-04-01 16:02:00
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d926309ds3.htm S-3 362503
2 EX-1.2 d926309dex12.htm EX-1.2 197413
3 EX-4.3 d926309dex43.htm EX-4.3 297097
4 EX-5.1 d926309dex51.htm EX-5.1 23375
5 EX-5.2 d926309dex52.htm EX-5.2 12346
6 EX-23.1 d926309dex231.htm EX-23.1 1275
7 EX-FILING FEES d926309dexfilingfees.htm EX-FILING FEES 38052
8 GRAPHIC g926309g0327131011671.jpg GRAPHIC 1690
9 GRAPHIC g926309g0327160637493.jpg GRAPHIC 2373
10 GRAPHIC g926309g03h01.jpg GRAPHIC 50054
  Complete submission text file 0001193125-25-070393.txt   1007977
Mailing Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121
Business Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-286302 | Film No.: 25799528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)